All In MedTech

Device Trial Radar · NCT07091682

Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold System in the Treatment of Subjects With Long de Novo Lesions

BIOTRONIK - Safety and Clinical Performance of the Drug Eluting Resorbable MAGnesium Scaffold (Freesolve) in the Treatment of Subjects With Long de Novo Lesions in Native Coronary Arteries: BIOMAG-LL

Last checked: Nov 20, 2026Latest source record: Oct 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

100

Planned (sponsor's estimate)

Start

Feb 18, 2025

Primary completion

Jun 2027

Study completion Jun 2031

Sponsor

Lead sponsor
Biotronik AGNot on our public-company list
Sponsor type
Industry
First posted
Jul 29, 2025

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The study objective is the assessment of safety and clinical performance of Freesolve 35- and 40-mm in de novo coronary artery lesions up to 38 mm length.

Conditions

  • Coronary Artery Disease
  • Atherosclerosis of Coronary Artery
  • Myocardial Ischemia
  • Ischemic Heart Disease
  • Acute Coronary Syndromes
  • Angina Pectoris

Interventions

  • Implantation of a Sirolimus-Eluting Resorbable Coronary Magnesium ScaffoldDevice

    Subjects with symptomatic coronary artery disease who qualify for percutaneous coronary intervention (PCI) will be treated with a sirolimus eluting resorbable coronary Magnesium scaffold

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants With Target Lesion Failure (TLF) at 12 Months Post-Index ProcedureTime frame: 12 Months

Locations

14 sites in 7 countries. Site status is shown where the registry gives one.

  • Katholisches Krankenhaus "St. Johann Nepomuk"

    Erfurt, Germany

  • Universitätsklinikum Halle (Saale)

    Halle, Germany

  • Klinikverbund Allgäu gGmbH

    Immenstadt and Kempten, Germany

11 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.